TuHURA Biosciences, Inc. HURA
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.72% | -1.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.38% | -10.29% | |||
| Operating Income | -16.38% | 10.29% | |||
| Income Before Tax | -22.38% | -11.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.38% | -11.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.38% | -11.47% | |||
| EBIT | -16.38% | 10.29% | |||
| EBITDA | -16.37% | 10.33% | |||
| EPS Basic | -14.81% | 1.57% | |||
| Normalized Basic EPS | -14.78% | 24.52% | |||
| EPS Diluted | -14.81% | 1.57% | |||
| Normalized Diluted EPS | -14.78% | 24.52% | |||
| Average Basic Shares Outstanding | 6.59% | 13.22% | |||
| Average Diluted Shares Outstanding | 6.59% | 13.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.18% | 0.10% | |||